Timothy P. Broke-Smith
Corporate Officer/Principal chez Diabetology Ltd.
Profil
Timothy P.
Broke-Smith is Corporate Development Officer of Diabetology Ltd.
He has experience in cellular and molecular biology research and corporate analysis.
Mr. Broke-Smith received a degree in Bioscience Enterprise from Cambridge University and a degree in Biology from Imperial College.
Postes actifs de Timothy P. Broke-Smith
| Sociétés | Poste | Début |
|---|---|---|
Diabetology Ltd.
 Diabetology Ltd. Miscellaneous Commercial ServicesCommercial Services Diabetology Ltd. offers biopharmaceutical research and development services. It develops Capsulin and novel Axcess oral form of insulin for diabetics that incorporates absorption enhancers with unmodified bioactive in a convenient encapsulated form. The company was founded by Roger New and Glen Travers in 2002 and is headquartered in St. Helier, Jersey. | Corporate Officer/Principal | - |
Formation de Timothy P. Broke-Smith
| University of Cambridge | Undergraduate Degree |
| Imperial College London | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Diabetology Ltd.
Diabetology Ltd. Miscellaneous Commercial ServicesCommercial Services Diabetology Ltd. offers biopharmaceutical research and development services. It develops Capsulin and novel Axcess oral form of insulin for diabetics that incorporates absorption enhancers with unmodified bioactive in a convenient encapsulated form. The company was founded by Roger New and Glen Travers in 2002 and is headquartered in St. Helier, Jersey. | Commercial Services |
